today-is-a-good-day
4.3 C
New York
Friday, March 29, 2024
HomeNewsAfricaWHO considers Madagascar COVID-19 drug for clinical trial

WHO considers Madagascar COVID-19 drug for clinical trial

The World Health Organisation (WHO) is considering Madagascar’s COVID Organics for clinical observation process.

The President of Madagascar, Andry Rajoelina made this known on Wednesday, saying that he and the Director-General of WHO, Tedros Ghebreyesus, had a successful virtual interaction on COVID Organics.

He said, “Successful exchange with Tedros Ghebreyesus who commends Madagascar’s efforts in the fight against COVID-19 and congratulates us for the discovery of COVID Organics.

“WHO will sign a confidentiality clause on its formulation and will support the clinical observations process in Africa.”

The Malagasy President said the meeting followed the invitation by WHO to register the drug for clinical trials, adding that his country would prove the effectiveness of the COVID Organics.

Advertisements

The country sent consignments of the herbal drug made from Artemisia annua to African nations.

President Muhammadu Buhari received the consignment apportioned to Nigeria from President Umaro Embaló of Guinea Bissau on Saturday, saying it would be subjected to scientific validation.

Advertisements

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

- Advertisment -

Most Popular

Recent Comments

Onuegbu Chuks Theophilus on Mikel Obi quits Super Eagles
Thomas H. Anderson on Roman Goddess_3
Oladimeji Emmanuel on Obama sends investors to Buhari